Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Luis Max Laban Seminario"'
Autor:
Edward Mezones-Holguin, Rocio Violeta Gamboa-Cardenas, Gadwyn Sanchez-Felix, José Chávez-Corrales, Luis Miguel Helguero-Santin, Luis Max Laban Seminario, Paula Alejandra Burela-Prado, Maribel Marilu Castro-Reyes, Fabian Fiestas
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Introduction: Biological products, including infliximab (INF), are a therapeutic option for various medical conditions. In the Peruvian Social Security (EsSalud), infliximab is approved for the treatment of rheumatoid arthritis, psoriasis, psoriatic
Externí odkaz:
https://doaj.org/article/a413291d6b2c40b38e015aa88857a8c3
Autor:
Maribel Marilu Castro-Reyes, Paula Alejandra Burela-Prado, Gadwyn Sanchez-Felix, José Chávez-Corrales, L.M. Helguero-Santin, Rocio Violeta Gamboa-Cardenas, Edward Mezones-Holguín, Luis Max Laban Seminario, Fabián Fiestas
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Frontiers in Pharmacology
Frontiers in Pharmacology
Introduction: Biological products, including infliximab (INF), are a therapeutic option for various medical conditions. In the Peruvian Social Security (EsSalud), infliximab is approved for the treatment of rheumatoid arthritis, psoriasis, psoriatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ea695a56e896bc59707774407444716
https://www.frontiersin.org/article/10.3389/fphar.2019.01010/full
https://www.frontiersin.org/article/10.3389/fphar.2019.01010/full